Mark Scarborough, MD
Orthopaedic Surgery · Gainesville, FLNPI 1285662940
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $211,389 of the $215,600 with a category attached, or 98.0%. Exactech, Inc. accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $51,780 and has fallen 99.9% since, to $31 in 2024. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $9373.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$215K
- Onkos Surgical, Inc.$117
- Carbofix Orthopedics Inc$31
Across 1 payment — averaging $1600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$2K
What the payments were for
- Royalty or licence$211,38998%
- Consulting fees$4,0002%
- Food & beverage$2120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 21 | $215,452 |
| Onkos Surgical, Inc. | 1 | $117 |
| Carbofix Orthopedics Inc | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EQUINOXE$215,389
How this compares
$215,600 in reported general payments places this provider in the 90th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 15 | $699 |
| Tramadol Hcl | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gainesville
- Rull James ToussaintGainesville$802K
- Richard VlasakGainesville$773K
- Kevin FarmerGainesville$772K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.